These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Asthma therapy and mortality. Ford RM Med J Aust; 1991 Mar; 154(6):427-8. PubMed ID: 1672035 [No Abstract] [Full Text] [Related]
7. The use of beta agonists and the risk of death and near death from asthma. Pearce N J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997 [No Abstract] [Full Text] [Related]
8. [Increased asthma fatality in chronic administration of beta agonists?]. Geisler LS Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666 [No Abstract] [Full Text] [Related]
9. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. Lanes SF; Birmann B; Raiford D; Walker AM J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532 [TBL] [Abstract][Full Text] [Related]
11. Fenoterol and asthma deaths. Grant IW Thorax; 1998 Jan; 53(1):77. PubMed ID: 9577529 [No Abstract] [Full Text] [Related]
12. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma. Furukawa CT; Kemp JP; Simons FE; Tinkelman DG Pediatrics; 1992 Oct; 90(4):639-40. PubMed ID: 1357623 [No Abstract] [Full Text] [Related]
13. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists". Pearce N; Beasley R; Crane J; Burgess C Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211 [No Abstract] [Full Text] [Related]
14. Beta 2-agonists and New Zealand asthma mortality. Burgess C; Crane J; Pearce N; Beasley R Lancet; 1991 Apr; 337(8747):982-3. PubMed ID: 1678066 [No Abstract] [Full Text] [Related]
15. [Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage]. Larsson K Lakartidningen; 1991 Oct; 88(44):3643-5. PubMed ID: 1682539 [No Abstract] [Full Text] [Related]
16. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma. Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051 [TBL] [Abstract][Full Text] [Related]
18. Long acting beta 2 agonists and the risk of life threatening asthma. Ernst P Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513 [No Abstract] [Full Text] [Related]
19. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Beasley R; Pearce N; Crane J; Burgess C Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161 [TBL] [Abstract][Full Text] [Related]
20. The saga of the New Zealand asthma mortality epidemic. N Z Med J; 1995 Mar; 108(995):91. PubMed ID: 7661939 [No Abstract] [Full Text] [Related] [Next] [New Search]